The accumulation of nucleoside adenosine in the tumor microenvironment suppresses various immune cells’ anti-tumor functions, including cytotoxic T cells and natural killer cells, by binding to adenosine A2A receptors (A2ARs) (5, 49). This evidence concerns the gene ADORA2A and neoplasm.